New Edge Advisors, LLC Omeros Corp Transaction History

New Edge Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$3.04 - $4.23 $6 - $8	2 New	2 $0
Q1 2022 May 13, 2022	SELL	$5.07 - $7.2 $642,196 - $911,995	-126,666 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$5.67 - $8.54 $349,249 - $526,029	61,596 Added 94.66%	126,666 $814,000
Q3 2021 Oct 29, 2021	BUY	$13.4 - $16.3 $148,163 - $180,229	11,057 Added 20.47%	65,070 $897,000
Q2 2021 Jul 22, 2021	BUY	$14.81 - $19.13 $638,503 - $824,751	43,113 Added 395.53%	54,013 $802,000
Q4 2020 Jan 27, 2021	BUY	$10.14 - $15.19 $5,070 - $7,595	500 Added 4.81%	10,900 $156,000
Q3 2020 Nov 03, 2020	BUY	$9.57 - $21.32 $99,528 - $221,728	10,400 New	10,400 $105,000
Q1 2020 May 04, 2020	SELL	$9.03 - $19.72 $93,460 - $204,102	-10,350 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$13.01 - $17.15 $134,653 - $177,502	10,350 New	10,350 $145,000

142

26.9M

959K

732K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $580M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.